Characteristic White_Hisp, N = 11,8091 White_Non-Hisp, N = 38,1091 Black, N = 7,9981 Chinese, N = 1,6231 Japanese, N = 7561 South_Asian, N = 1,0891 Other_Asian, N = 4,7871 Other, N = 1,5751
Nodes







    N0 6,503 (55%) 23,922 (63%) 4,529 (57%) 1,044 (64%) 525 (69%) 612 (56%) 3,049 (64%) 918 (58%)
    N1 3,886 (33%) 10,780 (28%) 2,506 (31%) 444 (27%) 181 (24%) 368 (34%) 1,308 (27%) 490 (31%)
    N2 921 (7.8%) 2,292 (6.0%) 639 (8.0%) 90 (5.5%) 34 (4.5%) 71 (6.5%) 307 (6.4%) 111 (7.0%)
    N3 499 (4.2%) 1,115 (2.9%) 324 (4.1%) 45 (2.8%) 16 (2.1%) 38 (3.5%) 123 (2.6%) 56 (3.6%)
Tumor size







    T0 3 (<0.1%) 4 (<0.1%) 7 (<0.1%) 1 (<0.1%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
    T1 5,249 (44%) 21,254 (56%) 3,535 (44%) 869 (54%) 462 (61%) 514 (47%) 2,446 (51%) 712 (45%)
    T2 5,004 (42%) 13,199 (35%) 3,342 (42%) 615 (38%) 246 (33%) 451 (41%) 1,857 (39%) 676 (43%)
    T3 1,190 (10%) 2,909 (7.6%) 805 (10%) 108 (6.7%) 42 (5.6%) 98 (9.0%) 407 (8.5%) 143 (9.1%)
    T4 363 (3.1%) 743 (1.9%) 309 (3.9%) 30 (1.8%) 6 (0.8%) 26 (2.4%) 77 (1.6%) 44 (2.8%)
Subtype







    HR+/HER2- 7,541 (64%) 26,537 (70%) 4,545 (57%) 1,179 (73%) 612 (81%) 731 (67%) 3,292 (69%) 1,036 (66%)
    HR+/HER2+ 1,740 (15%) 5,153 (14%) 1,091 (14%) 227 (14%) 70 (9.3%) 144 (13%) 776 (16%) 241 (15%)
    HR-/HER2- 1,875 (16%) 4,800 (13%) 1,894 (24%) 141 (8.7%) 55 (7.3%) 156 (14%) 417 (8.7%) 181 (11%)
    HR-/HER2+ 653 (5.5%) 1,619 (4.2%) 468 (5.9%) 76 (4.7%) 19 (2.5%) 58 (5.3%) 302 (6.3%) 117 (7.4%)
Grade







    G1 1,689 (14%) 7,387 (19%) 856 (11%) 301 (19%) 185 (24%) 159 (15%) 806 (17%) 269 (17%)
    G2 4,756 (40%) 16,406 (43%) 2,663 (33%) 742 (46%) 341 (45%) 476 (44%) 2,100 (44%) 642 (41%)
    G3 5,364 (45%) 14,316 (38%) 4,479 (56%) 580 (36%) 230 (30%) 454 (42%) 1,881 (39%) 664 (42%)
Stage (anatomical)







    IA 3,804 (32%) 16,448 (43%) 2,532 (32%) 672 (41%) 375 (50%) 372 (34%) 1,928 (40%) 526 (33%)
    IB 275 (2.3%) 1,084 (2.8%) 182 (2.3%) 43 (2.6%) 27 (3.6%) 25 (2.3%) 108 (2.3%) 29 (1.8%)
    IIA 3,314 (28%) 9,675 (25%) 2,350 (29%) 467 (29%) 191 (25%) 314 (29%) 1,333 (28%) 473 (30%)
    IIB 2,259 (19%) 5,707 (15%) 1,448 (18%) 239 (15%) 93 (12%) 213 (20%) 754 (16%) 291 (18%)
    IIIA 1,355 (11%) 3,474 (9.1%) 913 (11%) 133 (8.2%) 50 (6.6%) 105 (9.6%) 477 (10.0%) 165 (10%)
    IIIB 303 (2.6%) 606 (1.6%) 249 (3.1%) 24 (1.5%) 4 (0.5%) 22 (2.0%) 64 (1.3%) 35 (2.2%)
    IIIC 499 (4.2%) 1,115 (2.9%) 324 (4.1%) 45 (2.8%) 16 (2.1%) 38 (3.5%) 123 (2.6%) 56 (3.6%)
Stage (prognostic)







    IA 3,533 (30%) 15,582 (41%) 2,138 (27%) 665 (41%) 378 (50%) 346 (32%) 1,876 (39%) 505 (32%)
    IB 2,475 (21%) 7,854 (21%) 1,560 (20%) 353 (22%) 153 (20%) 234 (21%) 1,030 (22%) 345 (22%)
    IIA 2,513 (21%) 7,177 (19%) 1,523 (19%) 350 (22%) 118 (16%) 228 (21%) 1,027 (21%) 362 (23%)
    IIB 1,584 (13%) 3,976 (10%) 1,363 (17%) 133 (8.2%) 60 (7.9%) 154 (14%) 476 (9.9%) 190 (12%)
    IIIA 258 (2.2%) 537 (1.4%) 191 (2.4%) 18 (1.1%) 10 (1.3%) 21 (1.9%) 73 (1.5%) 29 (1.8%)
    IIIB 1,042 (8.8%) 2,204 (5.8%) 803 (10%) 84 (5.2%) 29 (3.8%) 89 (8.2%) 235 (4.9%) 101 (6.4%)
    IIIC 404 (3.4%) 779 (2.0%) 420 (5.3%) 20 (1.2%) 8 (1.1%) 17 (1.6%) 70 (1.5%) 43 (2.7%)
PAM cluster







    subtype_1+ 1,351 (11%) 6,421 (17%) 704 (8.8%) 264 (16%) 168 (22%) 139 (13%) 695 (15%) 219 (14%)
    subtype_1a 2,036 (17%) 8,129 (21%) 1,150 (14%) 386 (24%) 212 (28%) 210 (19%) 1,083 (23%) 280 (18%)
    subtype_1b 1,960 (17%) 5,836 (15%) 985 (12%) 249 (15%) 101 (13%) 190 (17%) 684 (14%) 250 (16%)
    subtype_1c 1,002 (8.5%) 3,237 (8.5%) 873 (11%) 164 (10%) 72 (9.5%) 93 (8.5%) 440 (9.2%) 151 (9.6%)
    subtype_1d 1,208 (10%) 2,970 (7.8%) 845 (11%) 120 (7.4%) 59 (7.8%) 101 (9.3%) 393 (8.2%) 138 (8.8%)
    subtype_2a 746 (6.3%) 2,663 (7.0%) 488 (6.1%) 104 (6.4%) 40 (5.3%) 61 (5.6%) 373 (7.8%) 96 (6.1%)
    subtype_2b 994 (8.4%) 2,490 (6.5%) 603 (7.5%) 123 (7.6%) 30 (4.0%) 83 (7.6%) 403 (8.4%) 145 (9.2%)
    subtype_3a 1,091 (9.2%) 3,088 (8.1%) 1,103 (14%) 87 (5.4%) 35 (4.6%) 89 (8.2%) 261 (5.5%) 108 (6.9%)
    subtype_3b 773 (6.5%) 1,669 (4.4%) 785 (9.8%) 51 (3.1%) 20 (2.6%) 65 (6.0%) 153 (3.2%) 72 (4.6%)
    subtype_4 648 (5.5%) 1,606 (4.2%) 462 (5.8%) 75 (4.6%) 19 (2.5%) 58 (5.3%) 302 (6.3%) 116 (7.4%)
Age 42.2 (5.6) 43.1 (5.3) 42.2 (5.7) 43.1 (5.0) 43.4 (4.9) 41.5 (5.6) 42.8 (5.0) 42.3 (5.7)
Mortality status







    0 10,480 (89%) 34,604 (91%) 6,506 (81%) 1,509 (93%) 716 (95%) 999 (92%) 4,471 (93%) 1,391 (88%)
    1 1,329 (11%) 3,505 (9.2%) 1,492 (19%) 114 (7.0%) 40 (5.3%) 90 (8.3%) 316 (6.6%) 184 (12%)
Cause of death







    Breast 1,094 (82%) 2,689 (77%) 1,167 (78%) 93 (82%) 29 (73%) 72 (80%) 263 (83%) 129 (70%)
    CVD 20 (1.5%) 97 (2.8%) 67 (4.5%) 1 (0.9%) 0 (0%) 0 (0%) 4 (1.3%) 5 (2.7%)
    Other 215 (16%) 719 (21%) 258 (17%) 20 (18%) 11 (28%) 18 (20%) 49 (16%) 50 (27%)
    Unknown 10,480 34,604 6,506 1,509 716 999 4,471 1,391
1 n (%); Mean (SD)